_id
69109cabccc777a4e85d5d63
Ticker
FDMT
Name
4D Molecular Therapeutics Inc
Exchange
NASDAQ
Address
5858 Horton Street, EmeryVille, CA, United States, 94608
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.4dmoleculartherapeutics.com
Description
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. Its lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. The company is also developing 4D-710, which is in early-stage study for the treatment of cystic fibrosis; 4D-175 that is in in preclinical stage for treating geographic atrophy; 4D-725, which is in preclinical stage for the treatment of alpha-1 anti-trypsin deficiency lung disease; and 4D-310 that is in Phase 1 clinical trial for treating Fabry disease. 4D Molecular Therapeutics, Inc. has collaboration and licensing agreements with Astellas Gene Therapies, Inc.; Arbor Biotechnologies, Inc.; and uniQure biopharma B.V. The company was founded in 2013 and is headquartered in Emeryville, California.
Last Close
11.08
Volume
660894
Current Price
10.64
Change
-3.9711191335740024
Last Updated
2025-11-30T18:37:05.157Z
Image
data:image/webp;base64,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
Ipo Date
2020-12-11T00:00:00.000Z
Market Cap
666195008
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.8804285714285713
Sentiment Sources
7
Rating
4
Target Price
33.1111
Strong Buy
5
Buy
4
Hold
2
Sell
0
Strong Sell
1
Current Quarter
2025-09-30
Revenue
90000
Cost Of Revenue
47238000
Gross Profit
-47148000
Operating Expenses
14037000
Operating Income
-61185000
Interest Expense
-
Pretax Income
-56876000
Net Income
-56876000
Eps
-1.0133568327022273
Dividends Per Share
-
Shares Outstanding
57135075
Income Tax Expense
-
EBITDA
-55615000
Operating Margin
-67983.33333333334
Total Other Income Expense Net
4309000
Cash
48555000
Short Term Investments
256508000
Receivables
-
Inventories
-
Total Current Assets
312377000
Property Plant Equipment
35060000
Total Assets
423982000
Payables
6863000
Short Term Debt
5695000
Long Term Debt
-
Total Liabilities
54999000
Equity
368983000
Depreciation
2003000
Change In Working Capital
4999000
Cash From Operations
-46498000
Capital Expenditures
91000
Cash From Investing
17778000
Cash From Financing
116000
Net Change In Cash
-28604000
PE
-
PB
1.6184597967928063
ROE
-15.414260277573764
ROA
-13.414720436244934
FCF
-46589000
Fcf Percent
-517.6555555555556
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
4.5
Growth Investing Score
3
Momentum Investing Score
3
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
90000
Quarters > 0 > income Statement > cost Of Revenue
47238000
Quarters > 0 > income Statement > gross Profit
-47148000
Quarters > 0 > income Statement > operating Expenses
14037000
Quarters > 0 > income Statement > operating Income
-61185000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-56876000
Quarters > 0 > income Statement > net Income
-56876000
Quarters > 0 > income Statement > eps
-1.0133568327022273
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
56126330
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-55615000
Quarters > 0 > income Statement > operating Margin
-67983.33333333334
Quarters > 0 > income Statement > total Other Income Expense Net
4309000
Quarters > 0 > balance Sheet > cash
48555000
Quarters > 0 > balance Sheet > short Term Investments
256508000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
312377000
Quarters > 0 > balance Sheet > property Plant Equipment
35060000
Quarters > 0 > balance Sheet > total Assets
423982000
Quarters > 0 > balance Sheet > payables
6863000
Quarters > 0 > balance Sheet > short Term Debt
5695000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
54999000
Quarters > 0 > balance Sheet > equity
368983000
Quarters > 0 > cash Flow > net Income
-56876000
Quarters > 0 > cash Flow > depreciation
2003000
Quarters > 0 > cash Flow > change In Working Capital
4999000
Quarters > 0 > cash Flow > cash From Operations
-46498000
Quarters > 0 > cash Flow > capital Expenditures
91000
Quarters > 0 > cash Flow > cash From Investing
17778000
Quarters > 0 > cash Flow > cash From Financing
116000
Quarters > 0 > cash Flow > net Change In Cash
-28604000
Quarters > 0 > ratios > PE
-1.0133568327022273
Quarters > 0 > ratios > PB
1.6184597967928063
Quarters > 0 > ratios > ROE
-15.414260277573764
Quarters > 0 > ratios > ROA
-13.414720436244934
Quarters > 0 > ratios > FCF
-46589000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-517.6555555555556
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
15000
Quarters > 1 > income Statement > cost Of Revenue
47951000
Quarters > 1 > income Statement > gross Profit
-47936000
Quarters > 1 > income Statement > operating Expenses
11520000
Quarters > 1 > income Statement > operating Income
-59456000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-54658000
Quarters > 1 > income Statement > net Income
-54658000
Quarters > 1 > income Statement > eps
-0.9773081170983844
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
55927091
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-58290000
Quarters > 1 > income Statement > operating Margin
-396373.3333333333
Quarters > 1 > income Statement > total Other Income Expense Net
4798000
Quarters > 1 > balance Sheet > cash
77159000
Quarters > 1 > balance Sheet > short Term Investments
216066000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
303287000
Quarters > 1 > balance Sheet > property Plant Equipment
37154000
Quarters > 1 > balance Sheet > total Assets
473637000
Quarters > 1 > balance Sheet > payables
8700000
Quarters > 1 > balance Sheet > short Term Debt
5721000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
52747000
Quarters > 1 > balance Sheet > equity
420890000
Quarters > 1 > cash Flow > net Income
-54658000
Quarters > 1 > cash Flow > depreciation
1888000
Quarters > 1 > cash Flow > change In Working Capital
5589000
Quarters > 1 > cash Flow > cash From Operations
-43377000
Quarters > 1 > cash Flow > capital Expenditures
66000
Quarters > 1 > cash Flow > cash From Investing
-13852000
Quarters > 1 > cash Flow > cash From Financing
862000
Quarters > 1 > cash Flow > net Change In Cash
-63805000
Quarters > 1 > ratios > PE
-0.9773081170983844
Quarters > 1 > ratios > PB
1.4138236789660006
Quarters > 1 > ratios > ROE
-12.986290954881321
Quarters > 1 > ratios > ROA
-11.540061270551076
Quarters > 1 > ratios > FCF
-43443000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-2896.2
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
14000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
14000
Quarters > 2 > income Statement > operating Expenses
53635000
Quarters > 2 > income Statement > operating Income
-53621000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-47972000
Quarters > 2 > income Statement > net Income
-47972000
Quarters > 2 > income Statement > eps
-0.8605761974906486
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
55744047
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-51867000
Quarters > 2 > income Statement > operating Margin
-383007.14285714284
Quarters > 2 > income Statement > total Other Income Expense Net
5649000
Quarters > 2 > balance Sheet > cash
133526000
Quarters > 2 > balance Sheet > short Term Investments
187911000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
332566000
Quarters > 2 > balance Sheet > property Plant Equipment
39116000
Quarters > 2 > balance Sheet > total Assets
515729000
Quarters > 2 > balance Sheet > payables
4151000
Quarters > 2 > balance Sheet > short Term Debt
5679000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
46006000
Quarters > 2 > balance Sheet > equity
469723000
Quarters > 2 > cash Flow > net Income
-47972000
Quarters > 2 > cash Flow > depreciation
1754000
Quarters > 2 > cash Flow > change In Working Capital
-7171000
Quarters > 2 > cash Flow > cash From Operations
-47758000
Quarters > 2 > cash Flow > capital Expenditures
631000
Quarters > 2 > cash Flow > cash From Investing
31948000
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-15810000
Quarters > 2 > ratios > PE
-0.8605761974906486
Quarters > 2 > ratios > PB
1.2626945243899064
Quarters > 2 > ratios > ROE
-10.21282756007264
Quarters > 2 > ratios > ROA
-9.301784464321377
Quarters > 2 > ratios > FCF
-48389000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-3456.3571428571427
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1000
Quarters > 3 > income Statement > cost Of Revenue
1784000
Quarters > 3 > income Statement > gross Profit
-1783000
Quarters > 3 > income Statement > operating Expenses
54334000
Quarters > 3 > income Statement > operating Income
-56117000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-49671000
Quarters > 3 > income Statement > net Income
-49671000
Quarters > 3 > income Statement > eps
-0.920792645804821
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
53943741
Quarters > 3 > income Statement > income Tax Expense
1
Quarters > 3 > income Statement > EBITDA
-61038000
Quarters > 3 > income Statement > operating Margin
-5611700
Quarters > 3 > income Statement > total Other Income Expense Net
6446000
Quarters > 3 > balance Sheet > cash
149336000
Quarters > 3 > balance Sheet > short Term Investments
275541000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
434932000
Quarters > 3 > balance Sheet > property Plant Equipment
40608000
Quarters > 3 > balance Sheet > total Assets
560384000
Quarters > 3 > balance Sheet > payables
4386000
Quarters > 3 > balance Sheet > short Term Debt
5637000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
49778000
Quarters > 3 > balance Sheet > equity
510606000
Quarters > 3 > cash Flow > net Income
-49671000
Quarters > 3 > cash Flow > depreciation
1784000
Quarters > 3 > cash Flow > change In Working Capital
-3718000
Quarters > 3 > cash Flow > cash From Operations
-45863000
Quarters > 3 > cash Flow > capital Expenditures
949000
Quarters > 3 > cash Flow > cash From Investing
7059000
Quarters > 3 > cash Flow > cash From Financing
601000
Quarters > 3 > cash Flow > net Change In Cash
-38203000
Quarters > 3 > ratios > PE
-0.920792645804821
Quarters > 3 > ratios > PB
1.1240788479571333
Quarters > 3 > ratios > ROE
-9.727852786688757
Quarters > 3 > ratios > ROA
-8.863743433074463
Quarters > 3 > ratios > FCF
-46812000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-46812
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
37000
Annuals > 0 > income Statement > cost Of Revenue
6705000
Annuals > 0 > income Statement > gross Profit
37000
Annuals > 0 > income Statement > operating Expenses
187878000
Annuals > 0 > income Statement > operating Income
-187841000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-160868000
Annuals > 0 > income Statement > net Income
-160868000
Annuals > 0 > income Statement > eps
-2.982143933992268
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
53943741
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-181136000
Annuals > 0 > income Statement > operating Margin
-507678.3783783784
Annuals > 0 > income Statement > total Other Income Expense Net
26973000
Annuals > 0 > balance Sheet > cash
149336000
Annuals > 0 > balance Sheet > short Term Investments
275541000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
434932000
Annuals > 0 > balance Sheet > property Plant Equipment
40608000
Annuals > 0 > balance Sheet > total Assets
560384000
Annuals > 0 > balance Sheet > payables
4386000
Annuals > 0 > balance Sheet > short Term Debt
5637000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
49778000
Annuals > 0 > balance Sheet > equity
510606000
Annuals > 0 > cash Flow > net Income
-160868000
Annuals > 0 > cash Flow > depreciation
6705000
Annuals > 0 > cash Flow > change In Working Capital
537000
Annuals > 0 > cash Flow > cash From Operations
-134585000
Annuals > 0 > cash Flow > capital Expenditures
3786000
Annuals > 0 > cash Flow > cash From Investing
-302437000
Annuals > 0 > cash Flow > cash From Financing
337250000
Annuals > 0 > cash Flow > net Change In Cash
-99772000
Annuals > 0 > ratios > PE
-2.982143933992268
Annuals > 0 > ratios > PB
1.231838286389114
Annuals > 0 > ratios > ROE
-31.505309377484792
Annuals > 0 > ratios > ROA
-28.70674394700777
Annuals > 0 > ratios > FCF
-138371000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-3739.7567567567567
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
20723000
Annuals > 1 > income Statement > cost Of Revenue
97096000
Annuals > 1 > income Statement > gross Profit
-76373000
Annuals > 1 > income Statement > operating Expenses
36494000
Annuals > 1 > income Statement > operating Income
-112867000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-100837000
Annuals > 1 > income Statement > net Income
-100837000
Annuals > 1 > income Statement > eps
-2.576969776208152
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
39130067
Annuals > 1 > income Statement > income Tax Expense
5581105
Annuals > 1 > income Statement > EBITDA
-108663000
Annuals > 1 > income Statement > operating Margin
-544.6460454567389
Annuals > 1 > income Statement > total Other Income Expense Net
12030000
Annuals > 1 > balance Sheet > cash
249108000
Annuals > 1 > balance Sheet > short Term Investments
39124000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
296588000
Annuals > 1 > balance Sheet > property Plant Equipment
31665000
Annuals > 1 > balance Sheet > total Assets
339891000
Annuals > 1 > balance Sheet > payables
3515000
Annuals > 1 > balance Sheet > short Term Debt
3149000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
32062000
Annuals > 1 > balance Sheet > equity
307829000
Annuals > 1 > cash Flow > net Income
-100837000
Annuals > 1 > cash Flow > depreciation
5749000
Annuals > 1 > cash Flow > change In Working Capital
630000
Annuals > 1 > cash Flow > cash From Operations
-75792000
Annuals > 1 > cash Flow > capital Expenditures
2771000
Annuals > 1 > cash Flow > cash From Investing
115717000
Annuals > 1 > cash Flow > cash From Financing
156832000
Annuals > 1 > cash Flow > net Change In Cash
196757000
Annuals > 1 > ratios > PE
-2.576969776208152
Annuals > 1 > ratios > PB
1.482175432529099
Annuals > 1 > ratios > ROE
-32.757472492845054
Annuals > 1 > ratios > ROA
-29.667452212621104
Annuals > 1 > ratios > FCF
-78563000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-3.7911016744679826
Annuals > 1 > health Score
35
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
3129000
Annuals > 2 > income Statement > cost Of Revenue
3880000
Annuals > 2 > income Statement > gross Profit
3129000
Annuals > 2 > income Statement > operating Expenses
113161000
Annuals > 2 > income Statement > operating Income
-110032000
Annuals > 2 > income Statement > interest Expense
6418000
Annuals > 2 > income Statement > pretax Income
-107494000
Annuals > 2 > income Statement > net Income
-101076000
Annuals > 2 > income Statement > eps
-3.124333390693353
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
32351221
Annuals > 2 > income Statement > income Tax Expense
-6418000
Annuals > 2 > income Statement > EBITDA
-106152000
Annuals > 2 > income Statement > operating Margin
-3516.5228507510383
Annuals > 2 > income Statement > total Other Income Expense Net
2538000
Annuals > 2 > balance Sheet > cash
52351000
Annuals > 2 > balance Sheet > short Term Investments
161203000
Annuals > 2 > balance Sheet > receivables
700000
Annuals > 2 > balance Sheet > inventories
-5788000
Annuals > 2 > balance Sheet > total Current Assets
220511000
Annuals > 2 > balance Sheet > property Plant Equipment
35347000
Annuals > 2 > balance Sheet > total Assets
261846000
Annuals > 2 > balance Sheet > payables
3322000
Annuals > 2 > balance Sheet > short Term Debt
2655000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
30509000
Annuals > 2 > balance Sheet > equity
231337000
Annuals > 2 > cash Flow > net Income
-107494000
Annuals > 2 > cash Flow > depreciation
3880000
Annuals > 2 > cash Flow > change In Working Capital
-1336000
Annuals > 2 > cash Flow > cash From Operations
-86685000
Annuals > 2 > cash Flow > capital Expenditures
11536000
Annuals > 2 > cash Flow > cash From Investing
-17050000
Annuals > 2 > cash Flow > cash From Financing
3085000
Annuals > 2 > cash Flow > net Change In Cash
-100650000
Annuals > 2 > ratios > PE
-3.124333390693353
Annuals > 2 > ratios > PB
1.630587570773374
Annuals > 2 > ratios > ROE
-43.69210286292292
Annuals > 2 > ratios > ROA
-38.6013152769185
Annuals > 2 > ratios > FCF
-98221000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-31.390540108660915
Annuals > 2 > health Score
35
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
18038000
Annuals > 3 > income Statement > cost Of Revenue
3020000
Annuals > 3 > income Statement > gross Profit
18038000
Annuals > 3 > income Statement > operating Expenses
89371000
Annuals > 3 > income Statement > operating Income
-71333000
Annuals > 3 > income Statement > interest Expense
3036000
Annuals > 3 > income Statement > pretax Income
-71317000
Annuals > 3 > income Statement > net Income
-68297000
Annuals > 3 > income Statement > eps
-2.4628909334946965
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
27730420
Annuals > 3 > income Statement > income Tax Expense
-3020000
Annuals > 3 > income Statement > EBITDA
-68313000
Annuals > 3 > income Statement > operating Margin
-395.45958531988026
Annuals > 3 > income Statement > total Other Income Expense Net
16000
Annuals > 3 > balance Sheet > cash
153001000
Annuals > 3 > balance Sheet > short Term Investments
94776000
Annuals > 3 > balance Sheet > receivables
47000
Annuals > 3 > balance Sheet > inventories
-8503000
Annuals > 3 > balance Sheet > total Current Assets
256280000
Annuals > 3 > balance Sheet > property Plant Equipment
28953000
Annuals > 3 > balance Sheet > total Assets
353487000
Annuals > 3 > balance Sheet > payables
4764000
Annuals > 3 > balance Sheet > short Term Debt
1231000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
34380000
Annuals > 3 > balance Sheet > equity
319107000
Annuals > 3 > cash Flow > net Income
-71317000
Annuals > 3 > cash Flow > depreciation
3020000
Annuals > 3 > cash Flow > change In Working Capital
-15534000
Annuals > 3 > cash Flow > cash From Operations
-69134000
Annuals > 3 > cash Flow > capital Expenditures
9110000
Annuals > 3 > cash Flow > cash From Investing
-172680000
Annuals > 3 > cash Flow > cash From Financing
118089000
Annuals > 3 > cash Flow > net Change In Cash
-123725000
Annuals > 3 > ratios > PE
-2.4628909334946965
Annuals > 3 > ratios > PB
1.0132547929064546
Annuals > 3 > ratios > ROE
-21.402538960286048
Annuals > 3 > ratios > ROA
-19.320936837846936
Annuals > 3 > ratios > FCF
-78244000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-4.337731455815501
Annuals > 3 > health Score
35
Valuation > metrics > PE
-1.0133568327022273
Valuation > metrics > PB
1.6184597967928063
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-15.414260277573764
Profitability > metrics > ROA
-18.207486466673284
Profitability > metrics > Net Margin
-631.9555555555555
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.14905564755015813
Risk > metrics > Interest Coverage
-48.52101506740682
Risk > final Score
-134
Risk > verdict
High
Liquidity > metrics > Current Ratio
24.874741200828158
Liquidity > metrics > Quick Ratio
24.874741200828158
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-5
Prev Risks > 1
5
Prev Risks > 2
40
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-11T01:18:09.262Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-27
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.532
Earnings History > 0 > eps Difference
0.532
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-10
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.01
Earnings History > 1 > eps Estimate
-1.01
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
0
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-11
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.98
Earnings History > 2 > eps Estimate
-0.73
Earnings History > 2 > eps Difference
-0.25
Earnings History > 2 > surprise Percent
-34.2466
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-07
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.86
Earnings History > 3 > eps Estimate
-0.8621
Earnings History > 3 > eps Difference
0.0021
Earnings History > 3 > surprise Percent
0.2436
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-26
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.9
Earnings History > 4 > eps Estimate
-0.8379
Earnings History > 4 > eps Difference
-0.0621
Earnings History > 4 > surprise Percent
-7.4114
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-07
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.79
Earnings History > 5 > eps Estimate
-0.7
Earnings History > 5 > eps Difference
-0.09
Earnings History > 5 > surprise Percent
-12.8571
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-08
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.63
Earnings History > 6 > eps Estimate
-0.7
Earnings History > 6 > eps Difference
0.07
Earnings History > 6 > surprise Percent
10
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-09
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.66
Earnings History > 7 > eps Estimate
-0.74
Earnings History > 7 > eps Difference
0.08
Earnings History > 7 > surprise Percent
10.8108
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-29
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.75
Earnings History > 8 > eps Estimate
-0.74
Earnings History > 8 > eps Difference
-0.01
Earnings History > 8 > surprise Percent
-1.3514
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-09
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.24
Earnings History > 9 > eps Estimate
-0.59
Earnings History > 9 > eps Difference
0.35
Earnings History > 9 > surprise Percent
59.322
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-09
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.77
Earnings History > 10 > eps Estimate
-0.81
Earnings History > 10 > eps Difference
0.04
Earnings History > 10 > surprise Percent
4.9383
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-10
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.88
Earnings History > 11 > eps Estimate
-0.89
Earnings History > 11 > eps Difference
0.01
Earnings History > 11 > surprise Percent
1.1236
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-15
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.84
Earnings History > 12 > eps Estimate
-0.79
Earnings History > 12 > eps Difference
-0.05
Earnings History > 12 > surprise Percent
-6.3291
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-08
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.79
Earnings History > 13 > eps Estimate
-0.91
Earnings History > 13 > eps Difference
0.12
Earnings History > 13 > surprise Percent
13.1868
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-11
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.87
Earnings History > 14 > eps Estimate
-0.85
Earnings History > 14 > eps Difference
-0.02
Earnings History > 14 > surprise Percent
-2.3529
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-12
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.82
Earnings History > 15 > eps Estimate
-0.81
Earnings History > 15 > eps Difference
-0.01
Earnings History > 15 > surprise Percent
-1.2346
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-28
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.85
Earnings History > 16 > eps Estimate
-0.86
Earnings History > 16 > eps Difference
0.01
Earnings History > 16 > surprise Percent
1.1628
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-10
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.82
Earnings History > 17 > eps Estimate
-0.8
Earnings History > 17 > eps Difference
-0.02
Earnings History > 17 > surprise Percent
-2.5
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-12
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.28
Earnings History > 18 > eps Estimate
-0.68
Earnings History > 18 > eps Difference
0.4
Earnings History > 18 > surprise Percent
58.8235
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-13
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.61
Earnings History > 19 > eps Estimate
-1.1
Earnings History > 19 > eps Difference
0.49
Earnings History > 19 > surprise Percent
44.5455
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-25
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-2.36
Earnings History > 20 > eps Estimate
-0.66
Earnings History > 20 > eps Difference
-1.7
Earnings History > 20 > surprise Percent
-257.5758
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-12-16
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-3.07
Earnings History > 21 > eps Estimate
-0.4
Earnings History > 21 > eps Difference
-2.67
Earnings History > 21 > surprise Percent
-667.5
Earnings History > 22 > period
2019-09-30
Earnings History > 22 > report Date
2019-12-31
Earnings History > 22 > date
2019-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-3.121
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-3.121
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-06-30
Earnings History > 23 > report Date
2019-09-30
Earnings History > 23 > date
2019-06-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-3.14
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-3.14
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-03-31
Earnings History > 24 > report Date
2019-06-30
Earnings History > 24 > date
2019-03-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-1.6089
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-1.6089
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2018-12-31
Earnings History > 25 > report Date
2019-03-31
Earnings History > 25 > date
2018-12-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-1.6089
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-1.6089
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2018-09-30
Earnings History > 26 > report Date
2018-12-31
Earnings History > 26 > date
2018-09-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.4298
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.4298
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2018-06-30
Earnings History > 27 > report Date
2018-09-30
Earnings History > 27 > date
2018-06-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.4298
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.4298
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-03-31
Earnings History > 28 > report Date
2018-06-30
Earnings History > 28 > date
2018-03-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.5164
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-0.5164
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2017-12-31
Earnings History > 29 > report Date
2018-03-31
Earnings History > 29 > date
2017-12-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.5164
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-0.5164
Earnings History > 29 > surprise Percent
-
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. Its lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. The company is also developing 4D-710, which is in early-stage study for the treatment of cystic fibrosis; 4D-175 that is in in preclinical stage for treating geographic atrophy; 4D-725, which is in preclinical stage for the treatment of alpha-1 anti-trypsin deficiency lung disease; and 4D-310 that is in Phase 1 clinical trial for treating Fabry disease. 4D Molecular Therapeutics, Inc. has collaboration and licensing agreements with Astellas Gene Therapies, Inc.; Arbor Biotechnologies, Inc.; and uniQure biopharma B.V. The company was founded in 2013 and is headquartered in Emeryville, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AIs 4D Molecular Therapeutics Inc (FDMT) positioned for future growth? Setenews
Read more →The Technical Signals Behind (FDMT) That Institutions Follow news.stocktradersdaily.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$33.1111
Analyst Picks
Strong Buy
5
Buy
4
Hold
2
Sell
0
Strong Sell
1
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 98.41% of the total shares of 4D Molecular Therapeutics Inc
1.
Bvf Inc(9.9123%)
since
2025/06/30
2.
RA Capital Management, LLC(9.7708%)
since
2025/06/30
3.
Goldman Sachs Group Inc(8.9059%)
since
2025/06/30
4.
BlackRock Inc(8.5879%)
since
2025/06/30
5.
Vanguard Group Inc(5.8598%)
since
2025/06/30
6.
Novo A/S(4.2824%)
since
2025/06/30
7.
HHG PLC(3.7566%)
since
2025/06/30
8.
Federated Hermes Inc(3.5701%)
since
2025/06/30
9.
Vanguard Total Stock Mkt Idx Inv(3.2209%)
since
2025/07/31
10.
Millennium Management LLC(3.177%)
since
2025/06/30
11.
Federated Hermes MDT SCC Institutional(2.3988%)
since
2025/06/30
12.
Federated Hermes MDT Small Cap Core IS(2.3988%)
since
2025/06/30
13.
iShares Russell 2000 ETF(2.1444%)
since
2025/08/31
14.
State Street Corp(2.0598%)
since
2025/06/30
15.
Morgan Stanley - Brokerage Accounts(1.9799%)
since
2025/06/30
16.
Geode Capital Management, LLC(1.9668%)
since
2025/06/30
17.
Bank of America Corp(1.9208%)
since
2025/06/30
18.
JPMorgan Chase & Co(1.9014%)
since
2025/06/30
19.
Janus Henderson Global Life Sciences(1.7883%)
since
2025/06/30
20.
Janus Henderson Global Life Sciences D(1.7883%)
since
2025/06/30
21.
Two Sigma Advisers, LLC(1.5918%)
since
2025/06/30
22.
Janus Global Life Science AUSD(1.5372%)
since
2025/06/30
23.
Janus Henderson Glb Life Scn I2 USD(1.5238%)
since
2025/07/31
24.
Assenagon Asset Management SA(1.3893%)
since
2025/06/30
25.
Two Sigma Investments LLC(1.1373%)
since
2025/06/30
26.
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)(1.1019%)
since
2025/06/30
27.
Fidelity Small Cap Index(0.8675%)
since
2025/06/30
28.
Federated Hermes MDT SCG Institutional(0.8466%)
since
2025/06/30
29.
Federated Hermes MDT Small Cap Growth IS(0.8466%)
since
2025/06/30
30.
Vanguard Institutional Extnd Mkt Idx Tr(0.7552%)
since
2025/07/31
31.
iShares Russell 2000 Value ETF(0.7457%)
since
2025/08/31
32.
Northern Trust Corp(0.7044%)
since
2025/06/30
33.
Peapod Lane Capital LLC(0.6821%)
since
2025/06/30
34.
Invesco Technology S&P US Sel Sec ETF(0.6502%)
since
2025/07/31
35.
iShares Biotechnology ETF(0.5254%)
since
2025/08/31
36.
JPM Thematics Genetic Thrps C2 dist USD(0.5134%)
since
2025/07/31
37.
DWS ESG Biotech LC(0.424%)
since
2025/07/31
38.
Vanguard Russell 2000 ETF(0.4054%)
since
2025/07/31
39.
Fidelity Extended Market Index(0.3912%)
since
2025/07/31
40.
State St Russell Sm Cap® Indx SL Cl I(0.3813%)
since
2025/08/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.532
Date
2025-09-30
EPS Actual
-1.01
EPS Estimate
-1.01
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.